n.a. (ASTX)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Astex Pharmaceuticals Announces Presentation Of Updated Results Of SGI-110-01 Study In Patients With Intermediate Or High Risk Relapsed Or Refractory Myelodysplastic Syndromes At The European Hematology Association

Astex Pharmaceuticals Announces Presentation Of Updated Results Of SGI-110-01 Study In Patients With Intermediate Or High Risk Relapsed Or Refractory Myelodysplastic Syndromes At The European Hematology Association

Results Confirm Clinical Activity of the Novel Hypomethylating Agent SGI-110 in Intermediate or High Risk MDS Patients Previously Treated With Azacitidine or Decitabine

Commit To Buy Astex Pharmaceuticals At $3.50, Earn 25.3% Annualized

Commit To Buy Astex Pharmaceuticals At $3.50, Earn 25.3% Annualized

Investors eyeing a purchase of Astex Pharmaceuticals Inc stock, but cautious about paying the going market price of $4.57/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2014 put at the $3.50 strike, which has a bid at the time of this writing of 55 cents.

Short Interest Moves 16% Higher For ASTX

Short Interest Moves 16% Higher For ASTX

The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, which shows a 804,039 share increase in total short interest for Astex Pharmaceuticals Inc , to 5,839,281, an increase of 15.97% since 04/15/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)

Astex Pharmaceuticals (Nasdaq:ASTX) has been downgraded by TheStreet Ratings from from a buy to hold.

Investing 'Systems' Take the Guesswork Out of Making Money

Investing 'Systems' Take the Guesswork Out of Making Money

Strategies that follow hard rules usually don't work. But some, it turns out, are legit.

TheStreet Ratings Top 10 Rating Changes

TheStreet Ratings Top 10 Rating Changes

TheStreet Ratings released rating changes on 80 U.S. common stocks for week ending March 1, 2013. 56 stocks were upgraded and 24 stocks were downgraded by our stock model.

Astex Pharmaceuticals Inc Stock Upgraded (ASTX)

Astex Pharmaceuticals Inc Stock Upgraded (ASTX)

Astex Pharmaceuticals (Nasdaq:ASTX) has been upgraded by TheStreet Ratings from a hold to buy.

5 Under-$10 Stocks Due to Surge

5 Under-$10 Stocks Due to Surge

Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)

Astex Pharmaceuticals Inc Stock Downgraded (ASTX)

Astex Pharmaceuticals (Nasdaq:ASTX) has been downgraded by TheStreet Ratings from from a buy to hold.

Astex Pharmaceuticals Inc Stock Upgraded (ASTX)

Astex Pharmaceuticals Inc Stock Upgraded (ASTX)

Astex Pharmaceuticals (Nasdaq:ASTX) has been upgraded by TheStreet Ratings from a hold to buy.